Sutro Biopharma, Inc. (STRO) Covered Calls

You can sell covered calls on Sutro Biopharma, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for STRO (prices last updated Fri 4:16 PM ET):

Sutro Biopharma, Inc. (STRO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.01 +0.16 2.00 2.09 1.3M - 0.2
Covered Calls For Sutro Biopharma, Inc. (STRO)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 21 2.5 0.05 2.04 2.5% 25.3%
Mar 21 2.5 0.15 1.94 7.7% 43.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.